Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 3,707 shares at $82.54 ($310K) on 2019-04-15, disclosed to the SEC on 2019-04-16.
Open-market sale of $310k RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.54 | 712 | $59K | 18.9% |
| 2 | $83.52 | 1,695 | $142K | 45.6% |
| 3 | $84.57 | 1,300 | $110K | 35.4% |
| Total | $83.70 avg | 3,707 | $310K | 100% |
| Filing → |
| RETA | SELL | 2019-10-21 | $1.7M | — | Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-10-15 | $2.1M | — | Filing → |